Turnstone Biologics Corp. - Common Stock, par value $0.001 per share (TSBX)

CUSIP: 90042W100

Q4 2023 13F Holders as of 31 Dec 2023

Holder snapshot 8 facts
Share change
-79,693
Reported price per share
$2.54
Number of holders
36
Value change
-$291,399
Number of buys
15
Number of sells
11
Security identity 2 facts
Shares outstanding
23,142,592

Security key

90042W100

Report period

Q4 2023

Institutions

36

Top holders

10

Ownership snapshot

Top reported holders of TSBX - Turnstone Biologics Corp. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
ORBIMED ADVISORS LLC
13D/G signal
Evidence rows
15
Latest as of
30 Sep 2023
13F Lead comparable stake: 13% Showing 1-6 of 15 holder rows.

Rank 2 holder

FMR LLC

13F
Ownership
12%
Position
$11.15M
13F
Holder Evidence Ownership % Position 12M Net Δ As of
ORBIMED ADVISORS LLC
13F
Company
13F
13%
$12,211,104
3,099,265 shares
30 Sep 2023
FMR LLC
13F
Company
13F
12%
$11,151,319
2,830,284 shares
30 Sep 2023
PFM Health Sciences, LP
13F
Company
13F
6.6%
$6,007,357
1,524,710 shares
30 Sep 2023
Point72 Asset Management, L.P.
13F
Company
13F
3.6%
$3,283,332
833,333 shares
30 Sep 2023
EVENTIDE ASSET MANAGEMENT, LLC
13F
Company
13F
3.1%
$2,790,769
708,317 shares
30 Sep 2023
CITADEL ADVISORS LLC
13F
Company
13F
3%
$2,663,417
687,452 shares
30 Sep 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
36
Shares
13,020,403
Rows available
36
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders
35
Q4 2023 holders
36
Holder diff
1
Investor Q3 2023 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2023 value Q4 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .